Hershey Trust CO Black Diamond Therapeutics, Inc. Transaction History

Hershey Trust CO

  • $396 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 12, 2021
SELL
$8.46 - $12.42 $108,592 - $159,423
-12,836 Closed
0 $0
Q1 2021

Apr 29, 2021
SELL
$22.23 - $34.75 $292,280 - $456,893
-13,148 Reduced 50.6%
12,836 $311,000
Q4 2020

Jan 21, 2021
BUY
$29.47 - $35.0 $522,385 - $620,410
17,726 Added 214.65%
25,984 $833,000
Q3 2020

Oct 23, 2020
BUY
$26.17 - $43.07 $216,111 - $355,672
8,258 New
8,258 $250,000

Others Institutions Holding BDTX

# of Institutions
121
Shares Held
48.8M
Call Options Held
1.84M
Put Options Held
1.93M
View Full List

About Black Diamond Therapeutics, Inc.

BDTX Quotes by TradingView
  • Ticker BDTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 36,339,500
  • Market Cap $89.4M
  • Description
  • Black Diamond Therapeutics, Inc., a biotechnology company, discover, develops, and commercializes medicines for patient with genetically defined tumors. It develops BDTX-189, an irreversible small molecule inhibitor that is designed to targets oncogenic proteins defined by the non-canonical epidermal growth factor receptor (EGFR) and human epide...
More about BDTX
Track This Portfolio

Track Hershey Trust CO Portfolio

Follow Hershey Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hershey Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Hershey Trust CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email